Abstract
In present study authors review all aspects of pulmonary drug delivery system; including need of drug delivery, different approaches for drug delivery and recent advancement in pulmonary drug delivery system. Review deals with drug targeting to pulmonary region for the treatment of various diseases such as chronic obstructive pulmonary disease, lung cancer, cystic fibrosis, tuberculosis, asthma, etc. All these disorders are difficult to be effectively cured through conventional modes of dosage system rather novel delivery systems have been developed which proved to be more site specific and less toxic. Apart from various formulations, different delivery devices such as metered dose inhalers (MDI), dry powder inhalers (DPI), nebulizers, aerosolizers, etc. have also improved drug targeting efficacy and reduced dose size in a more efficient manner. This review contains mainly the tabulated description of different categories of drugs and devices recently available in the market which makes it easily accessible for the researchers. Proteins, other biologicals and different marketed products are also successfully available to be delivered through pulmonary route for the better patient management. It can be concluded from whole study that different pulmonary delivery system possesses certain specificity for dosage formulations and serves as an important tool to deliver drugs to the target site.
Keywords: Pulmonary drug delivery, targeted drug delivery, delivery devices, protein and peptide delivery, Micronization, Spray freeze drying, Supercritical Fluid Crystallization, Nanoparticles, Insulin, Nanosuspensions
Current Drug Therapy
Title: Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Volume: 6 Issue: 2
Author(s): Anupama Singh, Rishabha Malviya and Pramod K. Sharma
Affiliation:
Keywords: Pulmonary drug delivery, targeted drug delivery, delivery devices, protein and peptide delivery, Micronization, Spray freeze drying, Supercritical Fluid Crystallization, Nanoparticles, Insulin, Nanosuspensions
Abstract: In present study authors review all aspects of pulmonary drug delivery system; including need of drug delivery, different approaches for drug delivery and recent advancement in pulmonary drug delivery system. Review deals with drug targeting to pulmonary region for the treatment of various diseases such as chronic obstructive pulmonary disease, lung cancer, cystic fibrosis, tuberculosis, asthma, etc. All these disorders are difficult to be effectively cured through conventional modes of dosage system rather novel delivery systems have been developed which proved to be more site specific and less toxic. Apart from various formulations, different delivery devices such as metered dose inhalers (MDI), dry powder inhalers (DPI), nebulizers, aerosolizers, etc. have also improved drug targeting efficacy and reduced dose size in a more efficient manner. This review contains mainly the tabulated description of different categories of drugs and devices recently available in the market which makes it easily accessible for the researchers. Proteins, other biologicals and different marketed products are also successfully available to be delivered through pulmonary route for the better patient management. It can be concluded from whole study that different pulmonary delivery system possesses certain specificity for dosage formulations and serves as an important tool to deliver drugs to the target site.
Export Options
About this article
Cite this article as:
Singh Anupama, Malviya Rishabha and K. Sharma Pramod, Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery, Current Drug Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157488511795304930
DOI https://dx.doi.org/10.2174/157488511795304930 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evidence for Anti-Cancer Properties of Blueberries: A Mini-Review
Anti-Cancer Agents in Medicinal Chemistry Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Current Cancer Drug Targets Human Aurora / Ipl1p Related Kinases
Current Genomics Versatile Applications of Nanotechnology-based Electronic Nose
Nanoscience & Nanotechnology-Asia Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]
Current Drug Targets EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases
Current Molecular Medicine Vitamin D and Lung Cancer
Current Respiratory Medicine Reviews Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
Current Drug Targets ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
Current Pharmaceutical Design Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry In Silico Machine Learning Methods in Drug Development
Current Topics in Medicinal Chemistry Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin
Anti-Cancer Agents in Medicinal Chemistry Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
Current Medicinal Chemistry New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology Bioprocessing of Plant In Vitro Systems for the Mass Production of Pharmaceutically Important Metabolites: Paclitaxel and its Derivatives
Current Medicinal Chemistry Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
Current Gene Therapy Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
Current Genomics Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer
Current Pharmaceutical Design